Congenital heart block: development of late-onset cardiomyopathy, a previously underappreciated sequela

J P Moak1, K S Barron, T J Hougen

  • 1Department of Cardiology, Children's National Medical Center, Washington, DC 20010, USA. jmoak@CNMC.org

Insights

Infants with congenital heart block (CHB) can develop dilated cardiomyopathy even with early pacing. Close monitoring of ventricular function is crucial for these patients.

Area of Science:

  • Pediatric Cardiology
  • Congenital Heart Disease
  • Electrophysiology

Background:

  • Isolated congenital heart block (CHB) typically has a good prognosis after pacemaker implantation.
  • Delayed pacing or associated heart defects can lead to early mortality in CHB patients.

Purpose of the Study:

  • To identify clinical features and risk factors for late-onset dilated cardiomyopathy in infants with CHB.
  • To assess the long-term outcomes of infants diagnosed with congenital heart block.

Main Methods:

  • A multi-institutional study analyzed 16 infants with congenital CHB.
  • Clinical data, serologic findings, echocardiograms, and myocardial biopsies were reviewed.
  • Cardiac pacing was initiated early in most patients.

Main Results:

  • 10 of 16 infants had findings consistent with neonatal lupus syndrome (NLS).
  • Despite early pacing, left ventricular function significantly decreased over time in most patients.
  • 12 of 16 infants developed congestive heart failure before 24 months; 4 died, and 7 required transplantation.

Conclusions:

  • Early cardiac pacing does not prevent the development of left ventricular cardiomyopathy in some infants with CHB.
  • Continuous monitoring of ventricular function is essential for infants with congenital heart block, in addition to rate and rhythm management.
Abstract

Related Concept Videos

Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...